SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Standard Chemical aug revenue NT$623.7M vs NT$578.7M

Standard Chemical & Pharmaceutical Co. Ltd. reported 2026 revenue of NT$623,714,000 versus NT$578,668,000 in 2025. Jan-Aug revenue was NT$4,745,375,000 versus NT$4,607,935,000. Figures are in new Taiwan dollars.

1720

Standard Chemical & Pharmaceutical Co. Ltd. reported revenue of NT$623,714,000 for 2026, compared with NT$578,668,000 in 2025, according to Taiwan figures in New Taiwan dollars. For Jan-Aug, revenue was NT$4,745,375,000 in 2026 versus NT$4,607,935,000 in 2025.

Source: Taiwan Stock Exchange.